Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity (Q34316288)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity |
scientific article |
Statements
1 reference
Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity (English)
1 reference
Yves Pommier
1 reference
Robert J Kinders
1 reference
Melinda Hollingshead
1 reference
Scott Lawrence
1 reference
Jiuping Ji
1 reference
Brian Tabb
1 reference
William M Bonner
1 reference
Larry Rubinstein
1 reference
Yvonne A Evrard
1 reference
Ralph E Parchment
1 reference
Joseph Tomaszewski
1 reference
James H Doroshow
1 reference
National Cancer Institute Phase 0 Clinical Trials Team
1 reference
5 October 2010
1 reference
1 reference
1 reference
Identifiers
1 reference